Hussein, Ayad Ahmed <br/><br/>
Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.  [electronic resource] 

 -  Pediatric blood & cancer  Aug 2013 
 - 1345-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.24493  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antilymphocyte Serum--administration & dosage<br/>Busulfan--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--etiology<br/>Graft Survival<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Infant<br/>Male<br/>Myeloablative Agonists--administration & dosage<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Rate<br/>Tissue Donors<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Vidarabine--administration & dosage<br/>beta-Thalassemia--mortality